These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 38442915)
1. PDE10A Mutation as an Emerging Cause of Childhood-Onset Hyperkinetic Movement Disorders: A Review of All Published Cases. Kalampokini S; Xiromerisiou G; Bargiotas P; Anastasiadou VC; Costeas P; Hadjigeorgiou GM Neuropediatrics; 2024 Aug; 55(4):217-223. PubMed ID: 38442915 [TBL] [Abstract][Full Text] [Related]
2. De Novo Mutations in PDE10A Cause Childhood-Onset Chorea with Bilateral Striatal Lesions. Mencacci NE; Kamsteeg EJ; Nakashima K; R'Bibo L; Lynch DS; Balint B; Willemsen MA; Adams ME; Wiethoff S; Suzuki K; Davies CH; Ng J; Meyer E; Veneziano L; Giunti P; Hughes D; Raymond FL; Carecchio M; Zorzi G; Nardocci N; Barzaghi C; Garavaglia B; Salpietro V; Hardy J; Pittman AM; Houlden H; Kurian MA; Kimura H; Vissers LE; Wood NW; Bhatia KP Am J Hum Genet; 2016 Apr; 98(4):763-71. PubMed ID: 27058447 [TBL] [Abstract][Full Text] [Related]
18. Cloning and characterization of a novel human phosphodiesterase that hydrolyzes both cAMP and cGMP (PDE10A). Fujishige K; Kotera J; Michibata H; Yuasa K; Takebayashi S; Okumura K; Omori K J Biol Chem; 1999 Jun; 274(26):18438-45. PubMed ID: 10373451 [TBL] [Abstract][Full Text] [Related]
19. Advances in Discovery of PDE10A Inhibitors for CNS-Related Disorders. Part 1: Overview of the Chemical and Biological Research. Jankowska A; Świerczek A; Wyska E; Gawalska A; Bucki A; Pawłowski M; Chłoń-Rzepa G Curr Drug Targets; 2019; 20(1):122-143. PubMed ID: 30091414 [TBL] [Abstract][Full Text] [Related]
20. Striatal phosphodiesterase mRNA and protein levels are reduced in Huntington's disease transgenic mice prior to the onset of motor symptoms. Hebb AL; Robertson HA; Denovan-Wright EM Neuroscience; 2004; 123(4):967-81. PubMed ID: 14751289 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]